Emrys Bio

Emrys Bio is a biotechnology company focused on drug re-innovation, a process of identifying and developing new therapeutic applications for existing pharmaceutical compounds. Founded by Dr. Michael Kinch, the company utilizes a proprietary platform to uncover hidden clinical potential and improve the efficacy of known drugs. Their approach aims to reduce the time and cost associated with traditional drug discovery by leveraging established safety profiles of previously studied molecules. The company's primary therapeutic focus includes oncology and infectious diseases, where they seek to address significant unmet medical needs through optimized molecular profiles. By re-engineering existing assets, Emrys Bio aims to streamline the path to clinical validation and commercialization.